ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation

Nan Yang; Lixun Guan; Zhanxiang Liu; Yi Ding; Chengying Zhu; Lan Luo; Feiyan Wang; Shu Fang; Zhe Gao; Zhenyang Gu; Chunji Gao

doi:10.12659/AOT.916004

14 June 2019 : Original article

ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation

Nan Yang^{ABCDEF 1}, Lixun Guan^{DEF 1}, Zhanxiang Liu^{BE 1}, Yi Ding^{B 1}, Chengying Zhu^{C 1}, Lan Luo^{B 1}, Feiyan Wang^{B 1}, Shu Fang^{B 1}, Zhe Gao^{F 1}, Zhenyang Gu^{A 1}, Chunji Gao^{ACDEFG 1*}

DOI: 10.12659/AOT.916004

Ann Transplant 2019; 24:350-358

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation

Your Privacy